Andera-backed Mineralys Therapeutics completes $192m Nasdaq IPO
French private equity investor Andera Partners’ portfolio company Mineralys Therapeutics has completed an oversubscribed initial public offering (IPO) worth $192m on the Nasdaq Global Select Market, priced at $16 per share.
Together...